1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > Germany In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture

Germany In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture

Summary

GlobalData’s new report, "Germany In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture", provides key market data on the Germany In Vitro Diagnostics market. The report provides value, in millions of US dollars within market segments - Immuno Chemistry, Clinical Chemistry, Infectious Diagnostics, Haematology, Microbiology Culture, Histology and Cytology and Genetic Testing.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- In Vitro Diagnostics market includes Immuno Chemistry, Clinical Chemistry, Infectious Diagnostics, Haematology, Microbiology Culture, Histology and Cytology and Genetic Testing.
- Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for In Vitro Diagnostics market.
- Global corporate-level profiles of key companies operating within the Germany In Vitro Diagnostics market.
- Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Abbott Laboratories, bioMerieux S.A., Danaher Corporation, Ortho-Clinical Diagnostics Inc. Becton, Dickinson and Company, Bio-Rad Laboratories, Inc. and Others.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table Of Contents

Germany In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 8
2 Introduction 10
2.1 What Is This Report About? 10
2.2 In Vitro Diagnostics Market Segmentation 10
2.3 Definitions of Markets Covered in the Report 13
3 In Vitro Diagnostics Market, Germany 26
3.1 In Vitro Diagnostics Market, Germany, Revenue ($m), 2007-2021 26
3.2 In Vitro Diagnostics Market, Germany, Revenue Mix ($m), 2014 28
3.3 In Vitro Diagnostics Market, Germany, Category Contribution by Revenue ($m), 2014 29
3.4 In Vitro Diagnostics Market, Germany, Category Comparison by Revenue ($m), 2007-2021 30
3.5 In Vitro Diagnostics Market, Germany, Revenue ($m), 2007-2014 32
3.6 In Vitro Diagnostics Market, Germany, Revenue ($m), 2014-2021 34
3.7 In Vitro Diagnostics Market, Germany, Company Share by Revenue ($m), 2014 36
4 Clinical Chemistry Market, Germany 38
4.1 Clinical Chemistry Market, Germany, Revenue Mix ($m), 2014 38
4.2 Clinical Chemistry Market, Germany, Segment Contribution (%), 2014 39
4.3 Clinical Chemistry Market, Germany, Revenue ($m), 2007-2014 40
4.4 Clinical Chemistry Market, Germany, Revenue ($m), 2014-2021 42
4.5 Clinical Chemistry Market, Germany, Distribution Share by Revenue ($m), 2013-2014 56
4.6 Clinical Chemistry Market, Germany, Company Share by Revenue ($m), 2014 57
5 Genetic Testing Market, Germany 59
5.1 Genetic Testing Market, Germany, Revenue Mix ($m), 2014 59
5.2 Genetic Testing Market, Germany, Segment Contribution (%), 2014 60
5.3 Genetic Testing Market, Germany, Revenue ($m), 2007-2014 61
5.4 Genetic Testing Market, Germany, Revenue ($m), 2014-2021 63
5.5 Genetic Testing Market, Germany, Distribution Share by Revenue ($m), 2013-2014 65
5.6 Genetic Testing Market, Germany, Company Share by Revenue ($m), 2014 66
6 Haematology Market, Germany 68
6.1 Haematology Market, Germany, Revenue Mix ($m), 2014 68
6.2 Haematology Market, Germany, Segment Contribution (%), 2014 69
6.3 Haematology Market, Germany, Revenue ($m), 2007-2014 70
6.4 Haematology Market, Germany, Revenue ($m), 2014-2021 72
6.5 Haematology Market, Germany, Distribution Share by Revenue ($m), 2013-2014 94
6.6 Haematology Market, Germany, Company Share by Revenue ($m), 2014 95
7 Histology And Cytology Market, Germany 97
7.1 Histology And Cytology Market, Germany, Revenue Mix ($m), 2014 97
7.2 Histology And Cytology Market, Germany, Segment Contribution (%), 2014 98
7.3 Histology And Cytology Market, Germany, Revenue ($m), 2007-2014 99
7.4 Histology And Cytology Market, Germany, Revenue ($m), 2014-2021 101
7.5 Histology And Cytology Market, Germany, Distribution Share by Revenue ($m), 2013-2014 103
7.6 Histology And Cytology Market, Germany, Company Share by Revenue ($m), 2014 104
8 Immuno Chemistry Market, Germany 106
8.1 Immuno Chemistry Market, Germany, Revenue Mix ($m), 2014 106
8.2 Immuno Chemistry Market, Germany, Segment Contribution (%), 2014 107
8.3 Immuno Chemistry Market, Germany, Revenue ($m), 2007-2014 109
8.4 Immuno Chemistry Market, Germany, Revenue ($m), 2014-2021 111
8.5 Immuno Chemistry Market, Germany, Distribution Share by Revenue ($m), 2013-2014 141
8.6 Immuno Chemistry Market, Germany, Company Share by Revenue ($m), 2014 142
9 Infectious Diagnostics Market, Germany 144
9.1 Infectious Diagnostics Market, Germany, Revenue Mix ($m), 2014 144
9.2 Infectious Diagnostics Market, Germany, Segment Contribution (%), 2014 145
9.3 Infectious Diagnostics Market, Germany, Revenue ($m), 2007-2014 147
9.4 Infectious Diagnostics Market, Germany, Revenue ($m), 2014-2021 149
9.5 Infectious Diagnostics Market, Germany, Distribution Share by Revenue ($m), 2013-2014 155
9.6 Infectious Diagnostics Market, Germany, Company Share by Revenue ($m), 2014 156
10 Microbiology Culture Market, Germany 158
10.1 Microbiology Culture Market, Germany, Revenue Mix ($m), 2014 158
10.2 Microbiology Culture Market, Germany, Segment Contribution (%), 2014 159
10.3 Microbiology Culture Market, Germany, Revenue ($m), 2007-2014 161
10.4 Microbiology Culture Market, Germany, Revenue ($m), 2014-2021 163
10.5 Microbiology Culture Market, Germany, Distribution Share by Revenue ($m), 2013-2014 169
10.6 Microbiology Culture Market, Germany, Company Share by Revenue ($m), 2014 170
11 Overview of Key Companies in Germany, In Vitro Diagnostics Market 172
11.1 Siemens Healthcare 172
11.2 F. Hoffmann-La Roche Ltd. 172
11.3 Abbott Laboratories 172
11.4 bioMerieux S.A. 173
11.5 Danaher Corporation 173
11.6 Becton, Dickinson and Company 173
11.7 Bio-Rad Laboratories, Inc. 174
11.8 Horiba, Ltd. 174
11.9 Mindray Medical International Limited 174
11.10 Thermo Fisher Scientific Inc. 175
11.11 Alere Inc. 175
11.12 Ortho-Clinical Diagnostics Inc. 175
11.13 Sysmex Corporation 176
11.14 DiaSorin S.p.A 176
11.15 PerkinElmer, Inc. 176
11.16 ELITech Group 177
12 In Vitro Diagnostics Market Pipeline Products 178
13 Financial Deals Landscape 184
13.1 Acquisition 184
13.2 Asset Transactions 186
13.3 Debt Offerings 188
13.4 Equity Offerings 192
13.5 Partnerships 195
13.6 Private Equity 236
13.7 Venture Financing 238
14 Recent Developments 250
14.1 Corporate Communications 250
14.2 Financial Announcements 261
14.3 Government and Public Interest 339
14.4 Legal And Regulatory 340
14.5 Other Significant Developments 341
14.6 Product News 354
14.7 Research And Development 366
14.8 Strategy And Business Planning 367
15 Appendix 377
15.1 Research Methodology 378
15.2 GlobalData Consulting 379
15.3 Contact Us 379
15.4 Disclaimer 380

1.1 List of Tables
Table 1: In Vitro Diagnostics Market, Germany, Revenue ($m), USD Constant, 2007-2021 34
Table 2: In Vitro Diagnostics Market, Germany, Category Contribution by Revenue ($m), 2014 36
Table 3: In Vitro Diagnostics Market, Germany, Category Comparison by Revenue ($m), USD Constant, 2007-2021 38
Table 4: In Vitro Diagnostics Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 40
Table 5: In Vitro Diagnostics Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 42
Table 6: In Vitro Diagnostics Market, Germany, Company Share by Revenue ($m), USD Constant, 2014 44
Table 7: Clinical Chemistry Market, Germany, Segment Contribution (%), 2014 46
Table 8: Clinical Chemistry Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 48
Table 9: Clinical Chemistry Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 50
Table 10: Clinical Chemistry Analyzers Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 52
Table 11: Therapeutic Drug Monitoring Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 54
Table 12: Urine Analysis Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 56
Table 13: Clinical Chemistry Analyzers Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 58
Table 14: Therapeutic Drug Monitoring Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 60
Table 15: Urine Analysis Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 62
Table 16: Clinical Chemistry Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2013-2014 63
Table 17: Clinical Chemistry Market, Germany, Company Share by Revenue ($m), USD Constant, 2014 65
Table 18: Genetic Testing Market, Germany, Segment Contribution (%), 2014 67
Table 19: Genetic Testing Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 69
Table 20: Genetic Testing Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 71
Table 21: Genetic Testing Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2013-2014 72
Table 22: Genetic Testing Market, Germany, Company Share by Revenue ($m), USD Constant, 2014 74
Table 23: Haematology Market, Germany, Segment Contribution (%), 2014 76
Table 24: Haematology Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 78
Table 25: Haematology Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 80
Table 26: Haematology Cell Counters Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 82
Table 27: Haematology Rapid Tests and POC Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 84
Table 28: Haematology Reagents Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 86
Table 29: Haemostasis Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 88
Table 30: Immunohaematology Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 90
Table 31: Haematology Cell Counters Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 92
Table 32: Haematology Rapid Tests and POC Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 94
Table 33: Haematology Reagents Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 96
Table 34: Haemostasis Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 98
Table 35: Immunohaematology Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 100
Table 36: Haematology Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2013-2014 101
Table 37: Haematology Market, Germany, Company Share by Revenue ($m), USD Constant, 2014 103
Table 38: Histology And Cytology Market, Germany, Segment Contribution (%), 2014 105
Table 39: Histology And Cytology Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 107
Table 40: Histology And Cytology Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 109
Table 41: Histology And Cytology Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2013-2014 110
Table 42: Histology And Cytology Market, Germany, Company Share by Revenue ($m), USD Constant, 2014 112
Table 43: Immuno Chemistry Market, Germany, Segment Contribution (%), 2014 115
Table 44: Immuno Chemistry Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 117
Table 45: Immuno Chemistry Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 119
Table 46: Anemia Tests Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 121
Table 47: Disease Specific Immunochemistry Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 123
Table 48: Endocrinology Tests Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 125
Table 49: IgE Allergy Blood Tests Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 127
Table 50: Immunochemistry Analyzers Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 129
Table 51: Immunochemistry Rapid Tests and POC Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 131
Table 52: Vitamins Tests Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 133
Table 53: Anemia Tests Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 135
Table 54: Disease Specific Immunochemistry Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 137
Table 55: Endocrinology Tests Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 139
Table 56: IgE Allergy Blood Tests Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 141
Table 57: Immunochemistry Analyzers Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 143
Table 58: Immunochemistry Rapid Tests and POC Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 145
Table 59: Vitamins Tests Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 147
Table 60: Immuno Chemistry Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2013-2014 148
Table 61: Immuno Chemistry Market, Germany, Company Share by Revenue ($m), USD Constant, 2014 150
Table 62: Infectious Diagnostics Market, Germany, Segment Contribution (%), 2014 153
Table 63: Infectious Diagnostics Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 155
Table 64: Infectious Diagnostics Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 157
Table 65: Infectious Diagnostics Rapid Tests and POC Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 159
Table 66: Infectious Diagnostics Rapid Tests and POC Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 161
Table 67: Infectious Diagnostics Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2013-2014 162
Table 68: Infectious Diagnostics Market, Germany, Company Share by Revenue ($m), USD Constant, 2014 164
Table 69: Microbiology Culture Market, Germany, Segment Contribution (%), 2014 167
Table 70: Microbiology Culture Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 169
Table 71: Microbiology Culture Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 171
Table 72: Microbiology Analyzers Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 173
Table 73: Microbiology Analyzers Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 175
Table 74: Microbiology Culture Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2013-2014 176
Table 75: Microbiology Culture Market, Germany, Company Share by Revenue ($m), USD Constant, 2014 178
Table 76: In Vitro Diagnostics Market Pipeline Products 185
Table 77: Roche Acquires Signature Diagnostics 191
Table 78: Beijing Leadman Biochemistry Plans to Acquire Stakes in Shanghai Units of DiaSys Diagnostic Systems for USD55.4 Million 192
Table 79: QIAGEN Acquires Circulating Tumor Cell Technology from AdnaGen 193
Table 80: Fresenius Raises USD300 Million in Private Placement of Notes 195
Table 81: Merck Raises USD801.4 Million in Private Placement of 0.23% Bonds Due 2017 196
Table 82: Merck Raises USD916 Million in Private Placement of 0.75% Bonds Due 2019 197
Table 83: Merck Raises USD629.7 Million in Private Placement of 1.375% Bonds Due 2022 198
Table 84: Epigenomics Raises USD5.6 Million in Rights Offering of Shares 199
Table 85: Epigenomics Raises USD5.3 Million in Private Placement of Shares 200
Table 86: Curetis Enters into Licensing Agreement with Acumen Research Labs for AcuSept 202
Table 87: Sony DADC Enter into Agreement with Fianostics 203
Table 88: Merck and Pfizer Enters into Agreement with Dako 204
Table 89: Scienion Partners with Axxin 206
Table 90: Seegene Enters into Co-Development Agreement with BD Life Sciences 207
Table 91: MdxHealth Enters into Licensing Agreement with Erasmus MC 208
Table 92: Instrumentation Laboratory Company Enters into Partnership with Thermo Fisher Scientific 209
Table 93: Sigma-Aldrich Enters into Distribution Agreement with LGC 210
Table 94: OvaGene Oncology Enters into Agreement with Etta Healthcare 211
Table 95: Apogenix Enters into Agreement with R-Biopharm 212
Table 96: InTouch Health Enters into Agreement with iSchemaView 213
Table 97: Axiogenesis Enters into Licensing Agreement with GE Healthcare 214
Table 98: Qiagen Forms Joint Venture with Biotype Diagnostics 215
Table 99: Qiagen Enters into Agreement with Hitachi High-Technologies 216
Table 100: Halozyme Therapeutics Enters into Co-Development Agreement with Ventana Medical Systems for Cancer Treatment 217
Table 101: Courtagen Life Sciences Enter into Distribution Agreement with Pronto Diagnostics for Next Generation Sequencing Tests 218
Table 102: DiaCarta Enters into Licensing Agreement with University of Potsdam for Colon Cancer Test 219
Table 103: IncellDx Enters into Licensing Agreement with Claremont BioSolutions 220
Table 104: Abbott Labs Enters into Agreement with Sekisui Diagnostics for Coagulation Testing 221
Table 105: AngioDynamics Enters into Licensing Agreement with EmboMedics 222
Table 106: Ion Beam Applications Enters into Distribution Agreement with Toshiba Medical Systems 223
Table 107: Biocartis Enters into Licensing and Development Agreement with Microbiome 224
Table 108: Esperite Enters into Agreement with Premaitha Health 225
Table 109: CBScientific Enters into Distribution Agreement with UTest 226
Table 110: Norgine Enters into Distribution Agreement with Arc Medical Design for Endocuff Vision 227
Table 111: GeneThera Enters into Co-Development Agreement with Hudson Robotics 228
Table 112: Nanospeed Enters into Distribution Agreement with DiaSys for Test4D 229
Table 113: Ellen Enters into Distribution Agreement with Biosynex 230
Table 114: KromaTiD Enters into Distribution Agreement with Tebu-bio 231
Table 115: Biolin Scientific Enters into Licensing Agreement with Nanion Technologies 232
Table 116: Ortho-Clinical Enters into Distribution Agreement with Quotient for MosaiQ 233
Table 117: Advanced Biological Labs, Inserm Transfert and Centre Hospitalier Universitaire Enter into Licensing Agreement for PyroVir software 235
Table 118: BioMerieux Enters into Licensing Agreement with Astute Medical 236
Table 119: MdxHealth Enters into Licensing Agreement with Oncgnostics for Epigenetic PCR Technology 237
Table 120: NoemaLife Enters into Distribution Agreement with Horiba Medical 238
Table 121: Protagen Enters into Agreement with Qiagen to Develop Novel Protein-Based Companion Diagnostics 239
Table 122: Clinical Genomics Enters into Licensing Agreement with CSIRO 240
Table 123: MoBiTec Enters into Distribution Agreement with Amoy Diagnostics 241
Table 124: MBio Diagnostics Enters into Co-Development Agreement with the Institute for Global Food Security and Scienion 242
Table 125: Cinven to Acquire Majority Stake in Synlab from BC Partners 243
Table 126: Biametrics Raises USD3.5 Million in Series A Venture Financing 245
Table 127: Lophius Biosciences Raises Funds through Venture Financing 247
Table 128: GNA Biosolutions Raises USD6.7 Million in Series B Financing 248
Table 129: Oncgnostics Raises USD1.1 Million in Series A Financing 250
Table 130: Protagen Raises USD12.5 Million in Venture Financing 251
Table 131: Ayoxxa Biosystems Raises USD2.9 Million in Extended Series B Venture Financing 253
Table 132: Curetis Raises USD18 Million in Extended Series B Venture Financing 254

1.2 List of Figures
Figure 1: In Vitro Diagnostics Market, Germany, Revenue ($m), USD Constant, 2007-2021 33
Figure 2: In Vitro Diagnostics Market, Germany, Revenue Mix ($m), 2014 35
Figure 3: In Vitro Diagnostics Market, Germany, Category Contribution (%), 2014 36
Figure 4: In Vitro Diagnostics Market, Germany, Category Comparison by Revenue ($m), USD Constant, 2007-2021 37
Figure 5: In Vitro Diagnostics Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 39
Figure 6: In Vitro Diagnostics Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 41
Figure 7: In Vitro Diagnostics Market, Germany, Company Share (%) 2014 43
Figure 8: Clinical Chemistry Market, Germany, Revenue Mix ($m), 2014 45
Figure 9: Clinical Chemistry Market, Germany, Segment Contribution (%), 2014 46
Figure 10: Clinical Chemistry Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 47
Figure 11: Clinical Chemistry Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 49
Figure 12: Clinical Chemistry Analyzers Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 51
Figure 13: Therapeutic Drug Monitoring Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 53
Figure 14: Urine Analysis Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 55
Figure 15: Clinical Chemistry Analyzers Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 57
Figure 16: Therapeutic Drug Monitoring Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 59
Figure 17: Urine Analysis Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 61
Figure 18: Clinical Chemistry Market, Germany, Company Share (%) 2014 64
Figure 19: Genetic Testing Market, Germany, Revenue Mix ($m), 2014 66
Figure 20: Genetic Testing Market, Germany, Segment Contribution (%), 2014 67
Figure 21: Genetic Testing Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 68
Figure 22: Genetic Testing Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 70
Figure 23: Genetic Testing Market, Germany, Company Share (%) 2014 73
Figure 24: Haematology Market, Germany, Revenue Mix ($m), 2014 75
Figure 25: Haematology Market, Germany, Segment Contribution (%), 2014 76
Figure 26: Haematology Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 77
Figure 27: Haematology Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 79
Figure 28: Haematology Cell Counters Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 81
Figure 29: Haematology Rapid Tests and POC Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 83
Figure 30: Haematology Reagents Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 85
Figure 31: Haemostasis Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 87
Figure 32: Immunohaematology Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 89
Figure 33: Haematology Cell Counters Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 91
Figure 34: Haematology Rapid Tests and POC Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 93
Figure 35: Haematology Reagents Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 95
Figure 36: Haemostasis Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 97
Figure 37: Immunohaematology Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 99
Figure 38: Haematology Market, Germany, Company Share (%) 2014 102
Figure 39: Histology And Cytology Market, Germany, Revenue Mix ($m), 2014 104
Figure 40: Histology And Cytology Market, Germany, Segment Contribution (%), 2014 105
Figure 41: Histology And Cytology Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 106
Figure 42: Histology And Cytology Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 108
Figure 43: Histology And Cytology Market, Germany, Company Share (%) 2014 111
Figure 44: Immuno Chemistry Market, Germany, Revenue Mix ($m), 2014 113
Figure 45: Immuno Chemistry Market, Germany, Segment Contribution (%), 2014 114
Figure 46: Immuno Chemistry Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 116
Figure 47: Immuno Chemistry Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 118
Figure 48: Anemia Tests Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 120
Figure 49: Disease Specific Immunochemistry Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 122
Figure 50: Endocrinology Tests Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 124
Figure 51: IgE Allergy Blood Tests Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 126
Figure 52: Immunochemistry Analyzers Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 128
Figure 53: Immunochemistry Rapid Tests and POC Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 130
Figure 54: Vitamins Tests Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 132
Figure 55: Anemia Tests Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 134
Figure 56: Disease Specific Immunochemistry Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 136
Figure 57: Endocrinology Tests Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 138
Figure 58: IgE Allergy Blood Tests Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 140
Figure 59: Immunochemistry Analyzers Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 142
Figure 60: Immunochemistry Rapid Tests and POC Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 144
Figure 61: Vitamins Tests Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 146
Figure 62: Immuno Chemistry Market, Germany, Company Share (%) 2014 149
Figure 63: Infectious Diagnostics Market, Germany, Revenue Mix ($m), 2014 151
Figure 64: Infectious Diagnostics Market, Germany, Segment Contribution (%), 2014 152
Figure 65: Infectious Diagnostics Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 154
Figure 66: Infectious Diagnostics Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 156
Figure 67: Infectious Diagnostics Rapid Tests and POC Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 158
Figure 68: Infectious Diagnostics Rapid Tests and POC Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 160
Figure 69: Infectious Diagnostics Market, Germany, Company Share (%) 2014 163
Figure 70: Microbiology Culture Market, Germany, Revenue Mix ($m), 2014 165
Figure 71: Microbiology Culture Market, Germany, Segment Contribution (%), 2014 166
Figure 72: Microbiology Culture Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 168
Figure 73: Microbiology Culture Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 170
Figure 74: Microbiology Analyzers Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 172
Figure 75: Microbiology Analyzers Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 174
Figure 76: Microbiology Culture Market, Germany, Company Share (%) 2014 177

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017-2021 Enteric Diseases Diagnostic Testing Market

2017-2021 Enteric Diseases Diagnostic Testing Market

  • $ 7500
  • Industry report
  • February 2017
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...

2017-2021 Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia--Supplier Shares, Competitive Strategies

2017-2021 Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia--Supplier Shares, Competitive Strategies

  • $ 7500
  • Industry report
  • January 2017
  • by Venture Planning Group

About this Report This new 389-page report from VPGMarketResearch.com presents detailed analysis of the Enteric Disease market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan.  Current ...

2017-2021 World Enteric Disease Market: Global Opportunities and Growth Strategies

2017-2021 World Enteric Disease Market: Global Opportunities and Growth Strategies

  • $ 7500
  • Industry report
  • February 2017
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.